Matthew Bush, MD
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Matthew Bush, MD sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Matthew Bush, MD: 4 sponsored US clinical trials, 1 recruiting.
Matthew Bush, MD sponsors 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Hearing Loss, Age-Related, with 1 trials.
Upper-quartile sponsor footprint
Matthew Bush, MD sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
Hearing Healthcare Assessment in Rural Communities
NCT05786794
Communities Helping the Hearing of Infants by Reaching Parents
NCT03875339
Comparison of In-Person Versus Remote Cochlear Implant Candidacy Evaluations
NCT02684175
Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators
NCT01917747
Therapeutic Areas
What is open in the Matthew Bush, MD pipeline
1 recruiting of 4 indexed (25% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Hearing Loss, Age-Related (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Matthew Bush, MD: open-pipeline peers nationwide
Peers matched on 4 registered trials and 25% open enrollment, not the therapeutic-area sidebar.
Matthew Bush, MD sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 25% open enrollment (± trial volume)
- AB Science · 25% recruiting · 8 trials
- Abbott Point of Care · 25% recruiting · 8 trials
- Accutar Biotechnology · 25% recruiting · 4 trials
- Adrienne G. Waks · 25% recruiting · 4 trials
Related
What to do with this Matthew Bush, MD page
4 registered trials is a research-attention snapshot, not an endorsement of Matthew Bush, MD or any single study.
- 1 of Matthew Bush, MD's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hearing Loss, Age-Related is the condition Matthew Bush, MD studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hearing Loss, Age-Related trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Matthew Bush, MD pipeline card: 4 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.